Pregled bibliografske jedinice broj: 1257497
A Critical Appraisal of the Diagnostic and Prognostic Utility of the Anti-Inflammatory Marker IL-37 in a Clinical Setting: A Case Study of Patients with Diabetes Type 2
A Critical Appraisal of the Diagnostic and Prognostic Utility of the Anti-Inflammatory Marker IL-37 in a Clinical Setting: A Case Study of Patients with Diabetes Type 2 // International Journal of Environmental Research and Public Health, 20 (2023), 4; 3695, 19 doi:10.3390/ijerph20043695 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1257497 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
A Critical Appraisal of the Diagnostic and
Prognostic Utility of the Anti-Inflammatory Marker
IL-37 in a Clinical Setting: A Case Study of
Patients with Diabetes Type 2
Autori
Bosnić, Zvonimir ; Babič, František ; Anderková, Viera ; Štefanić, Mario ; Wittlinger, Thomas ; Majnarić, Ljiljana Trtica
Izvornik
International Journal of Environmental Research and Public Health (1660-4601) 20
(2023), 4;
3695, 19
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
type 2 diabetes ; older adults ; chronic inflammation ; cytokine IL-37 ; diagnostic utility
Sažetak
Background: The role of the cytokine interleukin- 37 (IL-37) has been recognized in reversing inflammation-mediated metabolic costs. The aim was to evaluate the clinical utility of this cytokine as a diagnostic and prognostic marker in patients with type 2 diabetes (T2D). Methods: We included 170 older (median: 66 years) individuals with T2D (females: 95) and classified as primary care attenders to assess the association of factors that describe patients with plasma IL-37 levels (expressed as quartiles) using multinomial regression models. We determined the diagnostic ability of IL-37 cut-offs to identify diabetes- related complications or patient subgroups by using Receiver Operating Characteristic analysis (c-statistics). Results: Frailty status was shown to have a suppressive effect on IL-37 circulating levels and a major modifying effect on associations of metabolic and inflammatory factors with IL-37, including the effects of treatments. Situations in which IL-37 reached a clinically significant discriminating ability included the model of IL-37 and C-Reactive Protein in differentiating among diabetic patients with low– normal/high BMI ((<25/≥25 kg/m2), and the model of IL-37 and Thyroid Stimulating Hormone in discriminating between women with/without metabolic syndrome. Conclusions: The study has revealed limitations in using classical approaches in determining the diagnostic and prognostic utility of the cytokine IL-37 in patients with T2D and lain a foundation for new methodology approaches.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Osijek
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- Social Science Citation Index (SSCI)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE